Forbes.com, Feb. 26, 2020

by Mary Beth Pfeiffer

For two decades, Lyme disease has had dueling identities.

A burgeoning epidemic wrought by ticks. A raging controversy over why patients stay sick — and what to do for them.

Now, however, the medical model that spawned the Lyme Wars – enshrined in treatment guidelines that say short-course antibiotics are curative — is yielding to a more nuanced picture.

This new image is of a disease that outwits antibiotics and immune systems, is plagued by diagnostic failures, and is capable of inflicting lasting damage. It is an image that challenges the picture of medical certainty that has long been Lyme. READ MORE.